Wangzhi Wei
Wangzhi Wei
aThe Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
bDepartment of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada
a,b,
Wei Liu
Wei Liu
aThe Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
cDepartment of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada
a,c,
Clarissa A Cassol
Clarissa A Cassol
aThe Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
cDepartment of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada
a,c,
Weiyue Zheng
Weiyue Zheng
aThe Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
a,
Sylvia L Asa
Sylvia L Asa
aThe Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
cDepartment of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada
a,c,
Shereen Ezzat
Shereen Ezzat
aThe Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
cDepartment of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada
a,c
aThe Ontario Cancer Institute, University Health Network, University of Toronto, Toronto, Ontario, Canada
bDepartment of Medicine, University Health Network, University of Toronto, Toronto, Ontario, Canada
cDepartment of Pathology, University Health Network, University of Toronto, Toronto, Ontario, Canada
Citation Wei W, Liu W, Cassol CA, Zheng W, Asa SL, Ezzat S. 2018. Retraction for Wei et al., “The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-κB signaling.” Mol Cell Biol 38:e00298-18. https://doi.org/10.1128/MCB.00298-18.
Collection date 2018 Aug 15.